
    
      Potential subjects will be prescreened for PCS score; pre-qualified patients will be invited
      to the investigative site for informed consent and full screening within 30 days of
      randomization. Patients providing informed consent and meeting all study eligibility criteria
      will be enrolled in the study on the day of surgery (Day 1).

      Subjects will receive study drug just prior to anesthesia induction. Study assessments will
      be entered by subjects in the electronic diary from Day 1 through Day 21. Follow-up visits
      will occur on Days 7 and 21 (Â± 2 days).
    
  